Patterns of synthetic cannabinoid use in Australia

Drug and Alcohol Review

Volumn 32, Issue 2, 2013, Pages 141-146

  Barratt, Monica J ^a   Cakic, Vince ^b   Lenton, Simon ^a  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cannabinoids; Cannabis; Demography; Prevalence; Questionnaire

Indexed keywords

CANNABINOID;

ADDICTION; ADULT; ARTICLE; AUSTRALIA; FEMALE; HUMAN; INTERNET; MALE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SYNTHESIS; YOUNG ADULT;

ADULT; AUSTRALIA; CANNABINOIDS; FEMALE; HUMANS; INTERNET; MALE; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84874936416     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2012.00519.x     Document Type: Article

References (24)

1. Fattore L, Fratta W. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci 2011;5:60, doi:10.3389/fnbeh.2011.00060 4.
2. Hudson S, Ramsey J. The emergence and analysis of synthetic cannabinoids. Drug Test Anal 2011;3:466-478.
3. Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett 2010;197:157-162.
4. Seely KA, Lapoint J, Moran JH, Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 2012; doi:10.1016/j.pnpbp.2012.04.0175.
5. King SA. Cannabinoids and pain. Psychiatr Times 2008;25:56-59.
6. Hall W, Degenhardt L. Medical marijuana initiatives: are they justified? How successful are they likely to be? CNS Drugs 2003;17:689-697.
7. European Monitoring Centre for Drugs and Drug Addiction. 2010 Annual report on the state of the drugs problem in Europe. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction; 2010. Available at: http://www.emcdda.europa.eu/publications/annual-report/2010 (accessed May 2012; archived by WebCite® at http://www.webcitation.org/67V3oQCfN).
8. Wells DL, Ott CA. The 'new' marijuana. Ann Pharmacother 2011;45:414-417.
9. Warhaft G. Not for human consumption? The banning of synthetic cannabinoids. Of Substance 2011;9:14-17. Available at: http://www.ofsubstance.org.au/images/archive/pdf/OfSubstance_2011_3.pdf (accessed May 2012; archived by WebCite® at http://www.webcitation.org/67V3a7e57).
10. Schep LJ, Slaughter RJ, Temple WA, Nair SM, Gee P. Synthetic cannabinoid analogues-not repeating past mistakes. N Z Med J 2011;124:85-86.
11. United Nations Office on Drugs and Crime. Synthetic cannabinoids in herbal products. Vienna: United Nations Office on Drugs and Crime; 2011. Available at: http://www.unodc.org/documents/scientific/synthetic_cannabinoids.pdf (accessed May 2012; archived by WebCite® at http://www.webcitation.org/67V3yYA4m).
12. Advisory Council on the Misuse of Drugs. Consideration of the major cannabinoid agonists. London: Home Office; 2009. Available at: http://www.namsdl.org/documents/ACMDMajorCannabinoidReport.pdf (accessed May 2012; archived by WebCite® at http://www.webcitation.org/67V42xIcr).
13. Brown K. New Zealand bans synthetic cannabinoids. Br Med J 2011;343:d5395.
14. Therapeutic Goods Administration (TGA). Final decisions and reasons for decisions by delegates of the secretary to the Department of Health and Ageing. Canberra: Commonwealth of Australia; 2012. Available at: http://www.tga.gov.au/pdf/scheduling/scheduling-decisions-1202-final.pdf (accessed May 2012; archived by WebCite® at http://www.webcitation.org/67V4RZ8K5).
15. Therapeutic Goods Administration (TGA). Scheduling news. Reasons for delegate's final decisions, July 2011-synthetic cannabinoids. Canberra: Commonwealth of Australia; 2011. Available at: http://www.tga.gov.au/industry/scheduling-news.htm (accessed September 2011; archived by WebCite® at http://www.webcitation.org/61emq2fCM).
16. Hu X, Primack BA, Barnett TE, Cook RL. College students and use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy 2011;6:16, doi:10.1186/1747-597X-6-16 7.
17. Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend 2012;120:238-241.
18. Kerlinger FN, Lee HB. Foundations of behavioral research, 4th edn. Fort Worth, TX: Harcourt College Publishers, 2000.
19. Barratt MJ, Lenton S. Beyond recruitment? Participatory online research with people who use drugs. Int J Internet Res Ethics 2010;3:69-86.
20. Bowen A, Daniel C, Williams M, Baird G. Identifying multiple submissions in Internet research: preserving data integrity. AIDS Behav 2008;12:964-973.
21. Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med 2012; doi:10.1016/j.annemergmed.2012.03.007.
22. Every-Palmer S. Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug Alcohol Depend 2011;117:152-157.
23. Castellanos D, Singh S, Thornton G, Avila M, Moreno A. Synthetic cannabinoid use: a case series of adolescents. J Adolesc Health 2011;49:347-349.
24. Schifano F, Corazza O, Deluca P, etal. Psychoactive drug or mystical incense? Overview of the online available information on Spice products. Int J Culture Ment Health 2009;2:137-144.